Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population-Reference-Cited by-同舟云学术

Genetic and Nongenetic Factors Affecting Clopidogrel Response in the Egyptian Population

Published:2016-01-12 Issue:1 Volume:9 Page:23-28
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical And Translational Science

Author:

Khalil BM¹,Shahin MH²,Solayman MHM²³,Langaee T²,Schaalan MF¹⁴,Gong Y²,Hammad LN¹,Al‐Mesallamy HO⁵,Hamdy NM⁵,El‐Hammady WA⁶,Johnson JA²⁷

Affiliation:

1. Department of Biochemistry, Faculty of Pharmacy Misr International University Cairo Egypt

2. Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy University of Florida Gainesville Florida USA

3. Department of Clinical Pharmacy, Faculty of Pharmacy Ain Shams University Cairo Egypt

4. Department of Pharmacy Practice and Clinical Pharmacy Misr International University Cairo Egypt

5. Department of Biochemistry, Faculty of Pharmacy Ain Shams University Cairo Egypt

6. Department of Cardiology, Faculty of Medicine Ain Shams University Cairo Egypt

7. Division of Cardiovascular Medicine, Department of Medicine University of Florida Gainesville Florida USA

Funder

Misr International University, Cairo, Egypt and the University of Florida, Center of Pharmacogenomics and NIH

IGNITE Network

American Heart Association predoctoral fellowship

Embassy of the Arab Republic of Egypt

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12383

Reference41 articles.

1. Dual antiplatelet therapy with clopidogrel and aspirin after carotid artery stenting;Bhatt D.L.;J. Invasive Cardiol.,2001

2. A high maintenance dose of clopidogrel improves short‐term clinical outcomes in patients with acute coronary syndrome undergoing drug‐eluting stent implantation;Han Y.L.;Chin. Med. J. (Engl).,2009

3. Variability in platelet responsiveness to clopidogrel among 544 individuals

4. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

5. Variability in Individual Responsiveness to Clopidogrel

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of loss-of-function CYP2C19 variants on clinical outcomes in coronary artery disease patients treated with clopidogrel: A systematic meta-analysis approach;International Journal of Cardiology;2024-11

2. Comparative Bioequivalence Study of 2 Clopidogrel 75‐mg Tablet Formulations in Moroccan Volunteers;Clinical Pharmacology in Drug Development;2024-06-26

3. Genetic polymorphisms of CYP2C19 in ecuadorian population: An interethnic approach;Heliyon;2024-04

4. Advances and Perspectives in methods for identifying high platelet reactivity;Heliyon;2023-12

5. Role of genetic polymorphisms in clopidogrel response variability: a systematic review;Open Heart;2023-11